Works matching AU WANG Li-zhen


Results: 61
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.

    Published in:
    Cancer Communications, 2021, v. 41, n. 3, p. 279, doi. 10.1002/cac2.12136
    By:
    • Ju, Wu‐tong;
    • Liu, Ying;
    • Wang, Li‐zhen;
    • Li, Jiang;
    • Ren, Guo‐xing;
    • Sun, Jian;
    • Tu, Wen‐yong;
    • Hu, Yong‐jie;
    • Ji, Tong;
    • Yang, Wen‐jun;
    • Li, Jun;
    • He, Yue;
    • Wang, Yan‐an;
    • Zhang, Chen‐ping;
    • Zhong, Lai‐ping;
    • Zhang, Zhi‐yuan
    Publication type:
    Article